aminoquinoxaline (NeuroLifeSciences)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameaminoquinoxaline (NeuroLifeSciences)
Drug Alias NameCOP-SFNLS-7
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNLS Pharmaceutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNLS Pharmaceutics Ltd
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A